Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 4891 AL 4905

Levodopa challenge test: indications, protocol, and guide

Saranza G, Lang AE.

J Neurol. 2021 Sep;268(9):3135-3143. doi: 10.1007/s00415-020-09810-7. Epub 2020 Apr 24.

Hand dexterity assessment in Parkinson's disease: construct validity of the 9-Hole peg test for the more affected hand

Proud E, Morris ME, Bilney B, Miller KJ, Nijkrake MJ, Munneke M, McGinley JL.

Disabil Rehabil. 2021 Dec;43(26):3834-3838. doi: 10.1080/09638288.2020.1754474. Epub 2020 Apr 28.

Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease

Hirsch EC, Standaert DG.

Mov Disord. 2021 Jan;36(1):16-24. doi: 10.1002/mds.28075. Epub 2020 May 1.

Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature

Sarasso E, Agosta F, Piramide N, Filippi M.

J Neurol. 2021 Sep;268(9):3144-3179. doi: 10.1007/s00415-020-09863-8. Epub 2020 May 6.

Electroencephalogram in dementia with Lewy bodies: a systematic review

Chatzikonstantinou S, McKenna J, Karantali E, Petridis F, Kazis D, Mavroudis I.

Aging Clin Exp Res. 2021 May;33(5):1197-1208. doi: 10.1007/s40520-020-01576-2. Epub 2020 May 7.

Category learning in rodents using touchscreen-based tasks

Broschard MB, Kim J, Love BC, Freeman JH.

Genes Brain Behav. 2021 Jan;20(1):e12665. doi: 10.1111/gbb.12665. Epub 2020 Aug 4.

Shedding light on dyskinesias

Castela I, Hernandez LF.

Eur J Neurosci. 2021 Apr;53(7):2398-2413. doi: 10.1111/ejn.14777. Epub 2020 Jul 31.

Application of Next-Generation Sequencing in Neurodegenerative Diseases: Opportunities and Challenges

Shademan B, Biray Avci C, Nikanfar M, Nourazarian A.

Neuromolecular Med. 2021 Jun;23(2):225-235. doi: 10.1007/s12017-020-08601-7. Epub 2020 May 12.

Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a 'new form of the disease'

Gilbert F, Lancelot M.

J Med Ethics. 2021 Jan;47(1):20-25. doi: 10.1136/medethics-2019-106052. Epub 2020 May 14.

Effect of Opicapone Tablets on Levodopa and 3-O-Methyldopa Pharmacokinetics in Healthy Japanese Subjects: Phase 1 Study

Nomoto M, Takeda A, Iwai K, Nishimura A, Hattori N.

Clin Pharmacol Drug Dev. 2021 Feb;10(2):180-189. doi: 10.1002/cpdd.799. Epub 2020 May 16.

When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis

Marsili L, Vizcarra JA, Sturchio A, Dwivedi AK, Keeling EG, Patel D, Mishra M, Farooqi A, Merola A, Fasano A, Mata IF, Kauffman MA, Espay AJ.

J Neurol. 2021 Sep;268(9):3203-3211. doi: 10.1007/s00415-020-09892-3. Epub 2020 May 20.

Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression

Prosperini L, Tomassini V, Castelli L, Tacchino A, Brichetto G, Cattaneo D, Solaro CM.

J Neurol. 2021 Sep;268(9):3223-3237. doi: 10.1007/s00415-020-09918-w. Epub 2020 May 23.

Altered white matter microarchitecture in Parkinson's disease: a voxel-based meta-analysis of diffusion tensor imaging studies

Suo X, Lei D, Li W, Li L, Dai J, Wang S, Li N, Cheng L, Peng R, Kemp GJ, Gong Q.

Front Med. 2021 Feb;15(1):125-138. doi: 10.1007/s11684-019-0725-5. Epub 2020 May 26.

Pharmacokinetic Comparison of Capsule and Tablet Formulations of Opicapone in Healthy Japanese Subjects: Phase 1 Study

Nomoto M, Takeda A, Iwai K, Nishimura A, Hattori N.

Clin Pharmacol Drug Dev. 2021 Feb;10(2):173-179. doi: 10.1002/cpdd.802. Epub 2020 May 27.

Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors

Mohammadi S, Dolatshahi M, Rahmani F.

J Endocrinol Invest. 2021 Jan;44(1):1-13. doi: 10.1007/s40618-020-01314-5. Epub 2020 Jun 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias